Asia Pacific Digital Therapeutics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application [Diabetes, Cardiovascular Diseases, Central Nervous System (CNS) Disease, Respiratory Diseases, Smoking Cessation, Musculoskeletal Diseases, a

Asia Pacific Digital Therapeutics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application [Diabetes, Cardiovascular Diseases, Central Nervous System (CNS) Disease, Respiratory Diseases, Smoking Cessation, Musculoskeletal Diseases, and Others] and Distribution Channel (Patients, Providers, Payers, and Employers)

The Asia Pacific digital therapeutics market is expected to reach US$ 3,470.31 million by 2028 from US$ 767.23 million in 2021; it is estimated to grow at a CAGR of 24.1% from 2021 to 2028.

The growth of the market is attributed to the rising population with undiagnosed chronic conditions, such as CVDs and diabetes, and increasing number of start-ups in digital therapeutics. However, cyber threat and risk related to data security restrict the market growth.

Digital therapeutics help monitor and manage various chronic disorders, such as diabetes, heart disease, and respiratory infections. There have been various government initiatives that have supported the growth of the digital therapeutics market. In 2021, the Indian government initiated the National Digital Health Mission (NDHM) to increase the preference and adoption of e-healthcare models. It improved the healthcare sectors’ performance by inviting a large number of private players to enter into it. For example, Tattvan is India’s first-of-its-kind telemedicine company having a widespread telemedicine business with its “brick & mortar” model that provides medical diagnosis, prompt cure, guidance, and best consultancy to the patients of the tier-2, tier 3 cities, and tier-4 towns.

Government-aided reimbursements, and increasing number of patients being monitored are expected to encourage startups to enter the digital therapeutics industry. A large percentage of the population in the region is unaware of their diabetic status due to the occurrence of fewer symptoms. Similarly, as per data published in the 10th edition of the IDF Diabetes Atlas, ~239.7 million diabetic people from the age group 20-79 are estimated to be unaware of their disease. It is essential to diagnose diabetes early as it can lead to ailments, such as vision loss, kidney failure, and death in severe conditions. Additionally, people having undiagnosed diabetes opt for healthcare services more frequently than people without diabetes; thus, their healthcare spending is greater than healthy people. The rise in undiagnosed diabetes cases is attributed to inadequate screening facilities in low and high-income countries. With almost half of the global population unaware of diabetes, there is an urgent need to screen, diagnose, and provide appropriate care to people affected by diabetes. Digital therapeutics help detect the signs and symptoms of diabetes early by letting individuals monitor their health by themselves. Thus, the rise in this undiagnosed diabetic population is likely to boost the digital therapeutics market growth in the coming years.

Asia Pacific Digital Therapeutics Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Digital Therapeutics Market Segmentation

By Application

Diabetes Cardiovascular Diseases Central Nervous System (CNS) Disease Respiratory Smoking Cessation Musculoskeletal Diseases Others

By End User

Patients Providers Payers Employers By Country

Australia China India Japan South Korea Rest of APAC

Company Profiles

Propeller Health (Res Med) Noom, Inc Welldoc, Inc. Teladoc Health, Inc. Fitbit, Inc.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific digital therapeutics market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific digital therapeutics market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.